Headquarters Address:
Radnor Financial Ctr
555 E. Lancaster Ave.
Suite 520
Radnor, PA 19087
610.567.2380
610.567.2388 fax
New Jersey Office:
101 JFK Parkway
4th Floor
Short Hills
NJ 07078
973.467.1133 973.467.3007 fax
send us an email
Welcome to NewSpring Capital
NewSpring Capital, based in Radnor, Pennsylvania, and Short Hills, New Jersey, is a leading provider of private equity capital to the Mid-Atlantic region. NewSpring Capital currently manages over $500 million across three distinct investment strategies through its family of funds.
Across all funds, NewSpring Capital’s investment professionals include eight partners with significant experience as private equity investors, operating managers, and industry leaders at the CEO level. The firm’s highly cohesive investment team has a strong track record of investing in both private and public transactions, collectively representing more than 100 years of experience investing over $1 billion.
All three NewSpring Capital funds work closely together. Yet each fund maintains its own dedicated senior management team, investment committee and limited partner advisory board. While in some cases the funds may co-invest, each fund operates independently, investing in non-competitive asset classes, stages, and industries.
The NewSpring Capital family of funds includes:
NewSpring Ventures provides equity capital to growth and expansion stage companies with a focus on business services, enabling technologies, and information technology.
NewSpring Health Capital provides equity capital to healthcare companies within the life sciences, healthcare services, and medical device sectors.
NewSpring Mezzanine Capital provides mezzanine capital for expansion stage and buy out opportunities in the business services, health care, information technology, and specialty manufacturing sectors.
News
THERMACORE names new Board Member
NewSpring Capital Adds Gregory Barger to Bolster Mezzanine Team
NewSpring Capital portfolio Company CFO recognized as NJTC CFO of The Year
NewSpring Capital and Portfolio Company CEOs and Partner Recognized as E&Y Entrepreneur of the Year Award Regional Finalists
OTHERA Announces Positive Interim Phase 2 Results of OT-551 Eye Drop Treatment for Dry AMD
Core Essence Receives FDA Approval for SECURUSTM, an Innovative Knotless Suture Anchor System
Core Essence Orthopaedics Names John C. Moran Chairman of the Board
ProfitPoint Inc. Acquires Merchant Portfolio from ePayment Consultants
Barr Pharmaceuticals' Bruce L. Downey to Join NewSpring Capital
NewSpring Capital Announces Mezzanine Investment in IDC Westinghouse




